A key molecular event in prion diseases is the conversion of the prion protein (PrP) from its normal cellular form (PrPC) to the disease-specific form (PrPSc). The transition from PrPC to PrPSc involves a major conformational change, resulting in amorphous protein aggregates and fibrillar amyloid deposits with increased beta-sheet structure. Using recombinant PrP refolded into a beta-sheet-rich form (beta-PrP) we have studied the fibrillization of beta-PrP both in solution and in association with raft membranes. In low ionic strength thick dense fibrils form large networks, which coexist with amorphous aggregates. High ionic strength results in less compact fibrils, that assemble in large sheets packed with globular PrP particles, resemblin...
Aggregation and misfolding of the prion protein (PrP) are thought to be the cause of a family of let...
Transmissible spongiform encephalopathies (TSE) are a heterogeneous group of neurodegenerative disor...
The fibrillogenic peptide corresponding to the residues 106-126 of the prion protein sequence (PrP 1...
A key molecular event in prion diseases is the conversion of the prion protein (PrP) from its normal...
Prion diseases are characterised at autopsy by neuronal loss and accumulation of amorphous protein a...
Prion diseases are characterised at autopsy by neuronal loss and accumulation of amorphous protein a...
A key molecular event in prion diseases is the conversion of the prion protein (PrP) from its normal...
A key molecular event in prion diseases is the conversion of PrP (prion protein) from its normal cel...
In vivo under pathological conditions, the normal cellular form of the prion protein, PrP(C) (residu...
In vivo under pathological conditions, the normal cellular form of the prion protein, PrP(C) (residu...
Prion diseases are associated with a major refolding event of the normal cellular prion protein, PrP...
none3noPrion diseases, also known as transmissible spongiform encephalopathies (TSEs), are a group o...
Transmissible spongiform encephalopathies (TSEs) or prion diseases are serious neurological ailments...
Transmissible spongiform encephalopathies (TSEs) or prion diseases are serious neurological ailments...
Aggregation and misfolding of the prion protein (PrP) are thought to be the cause of a family of let...
Aggregation and misfolding of the prion protein (PrP) are thought to be the cause of a family of let...
Transmissible spongiform encephalopathies (TSE) are a heterogeneous group of neurodegenerative disor...
The fibrillogenic peptide corresponding to the residues 106-126 of the prion protein sequence (PrP 1...
A key molecular event in prion diseases is the conversion of the prion protein (PrP) from its normal...
Prion diseases are characterised at autopsy by neuronal loss and accumulation of amorphous protein a...
Prion diseases are characterised at autopsy by neuronal loss and accumulation of amorphous protein a...
A key molecular event in prion diseases is the conversion of the prion protein (PrP) from its normal...
A key molecular event in prion diseases is the conversion of PrP (prion protein) from its normal cel...
In vivo under pathological conditions, the normal cellular form of the prion protein, PrP(C) (residu...
In vivo under pathological conditions, the normal cellular form of the prion protein, PrP(C) (residu...
Prion diseases are associated with a major refolding event of the normal cellular prion protein, PrP...
none3noPrion diseases, also known as transmissible spongiform encephalopathies (TSEs), are a group o...
Transmissible spongiform encephalopathies (TSEs) or prion diseases are serious neurological ailments...
Transmissible spongiform encephalopathies (TSEs) or prion diseases are serious neurological ailments...
Aggregation and misfolding of the prion protein (PrP) are thought to be the cause of a family of let...
Aggregation and misfolding of the prion protein (PrP) are thought to be the cause of a family of let...
Transmissible spongiform encephalopathies (TSE) are a heterogeneous group of neurodegenerative disor...
The fibrillogenic peptide corresponding to the residues 106-126 of the prion protein sequence (PrP 1...